Archive

Rebel Category: REBEL EM

The EAST-AFNET 4 Trial: Early Rhythm-Control Therapy in Patients with Atrial Fibrillation

Background: Approximately one in four adults over forty-five years of age will develop atrial fibrillation (AF) during their lifetime. There is a clear association between AF and premature death, ischemic stroke, and cardiovascular events in the first year after atrial ...

Read More
Cardiovascular

The DANMASK-19 Trial: Masks Not Effective to Prevent COVID-19? Not So Fast!!!

Background: Face masks can reduce transmission of respiratory viruses by both being a potential physical barrier and by reducing droplet transmission.  Additionally, the presence of a mask reduces the users frequency of touching their face which may also reduce transmission.  ...

Read More
Infectious Disease

A COVID-19 Update that is Long Overdue

Background: There have been lots of trials sitting on my computer desktop awaiting my review, but like many of you time has been thin from clinical work and increasing cases of COVID-19 where I work.  I thought it might be ...

Read More
Infectious Disease

Orbital Compartment Syndrome: Pearls and Pitfalls for the ED Physician

Orbital compartment syndrome (OCS) is a rare, vision-threatening diagnosis that requires rapid identification and immediate treatment for preservation of vision.1-4 As with other compartment syndromes, rapidly increasing and sustained high intraocular pressures (IOP) can result in devastating consequences. OCS causes ...

Read More
Head, Eye, Ear, Nose, and ThroatTrauma

Should we Rubber STAAMP Prehospital TXA?

Background: It almost seems that when it comes to the use of the antifibrinolytic agent tranexamic acid (TXA) in trauma, one argument has just been completed and another one comes up right behind it. Let’s take a step back. Most ...

Read More
Trauma

Sponsored